Question 1

What doses of ibogaine are used for addiction treatment?

Accepted Answer

Some published ibogaine protocols report weight-based ranges, but they are not self-treatment instructions. Ibogaine has a narrow therapeutic window and has been associated with fatal arrhythmias; appropriately licensed medical teams use cardiac and laboratory screening, medication review, and continuous monitoring. This summary cannot determine eligibility or a safe amount.

Question 2

How is ibogaine different from other psychedelics in terms of safety?

Accepted Answer

Ibogaine is associated with serious cardiac risk, including QT prolongation and potentially fatal arrhythmias. Published clinical protocols generally require cardiac and laboratory screening and exclude many medications and conditions. Anyone considering treatment should consult an appropriately licensed clinician; this summary cannot determine eligibility. Psilocybin and LSD have different cardiovascular profiles but still can affect heart rate and blood pressure and may present risks for some people.